A wealthy US businessman has given US$5 million to the University of Texas at San Antonio College of Sciences, to establish the new Oskar Fischer Project - an initiative that will "engage the world's brightest minds in a comprehensive literature review, with the goal of synthesising that information into one simple explanation for the cause of Alzheimer's disease".
The initiative by James Truchard will award a grand prize of $2 million, two second place prizes worth $500,000 each and four third place prizes of $250,000 each.
Truchard has been inspired by the work of the late Oskar Fischer, a Jewish pioneer in neuroscience who studied dementia at the same time as Alois Alzheimer.
He said despite over 130,000 research papers published on the condition, no definitive explanation and cure had been found.
A call for proposals under the project will open in Feb 2019.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Nov 18
